Epithelial-to-mesenchymal transition (EMT) has been implicated in the progression of bladder cancer. To study its contribution to bladder cancer metastasis, we established new xenograft models derived from human bladder cancer cell lines utilizing an orthotopic “recycling” technique that allowed us to isolate and examine the primary tumor and its corresponding circulating tumor cells (CTC’s) and metastatic lesions. Using whole genome mRNA expression profiling, we found that a reversible epithelial-to-mesenchymal transition (EMT) characterized by TGFβ pathway activation and SNAIL expression was associated with the accumulation of CTCs. Finally, we observed that conditional silencing of SNAIL completely blocked CTC production and regional/dis...
Metastasis accounts for the majority of treatment-refractory cancers and poor prognosis of the disea...
Artículo de publicación ISIThe incidence and mortality rates of prostate cancer (PCa) are increasing...
Non-muscle-invasive bladder cancer is the most common form of bladder cancer. The main problem in ma...
Epithelial-to-mesenchymal transition (EMT) has been implicated in the progression of bladder cancer....
Introduction The majority of prostate cancer (PCa) deaths occur due to the metastatic spread of tumo...
Management of unresectable urothelial cancer (UC) has been a clinical challenge for decades. While d...
Epithelial-to-mesenchymal transition (EMT) increases cell migration and invasion, and facilitates me...
AbstractManagement of unresectable urothelial cancer (UC) has been a clinical challenge for decades....
The transcription factor Snail1 induces epithelial-to-mesenchymal transition (EMT) in tumor epitheli...
Abstract Background The epithelial to mesenchymal tra...
Tumor-related death is primarily caused by metastasis; consequently, understanding, preventing, and ...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with u...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Metastasis accounts for the majority of treatment-refractory cancers and poor prognosis of the disea...
Artículo de publicación ISIThe incidence and mortality rates of prostate cancer (PCa) are increasing...
Non-muscle-invasive bladder cancer is the most common form of bladder cancer. The main problem in ma...
Epithelial-to-mesenchymal transition (EMT) has been implicated in the progression of bladder cancer....
Introduction The majority of prostate cancer (PCa) deaths occur due to the metastatic spread of tumo...
Management of unresectable urothelial cancer (UC) has been a clinical challenge for decades. While d...
Epithelial-to-mesenchymal transition (EMT) increases cell migration and invasion, and facilitates me...
AbstractManagement of unresectable urothelial cancer (UC) has been a clinical challenge for decades....
The transcription factor Snail1 induces epithelial-to-mesenchymal transition (EMT) in tumor epitheli...
Abstract Background The epithelial to mesenchymal tra...
Tumor-related death is primarily caused by metastasis; consequently, understanding, preventing, and ...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with u...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its under...
Metastasis accounts for the majority of treatment-refractory cancers and poor prognosis of the disea...
Artículo de publicación ISIThe incidence and mortality rates of prostate cancer (PCa) are increasing...
Non-muscle-invasive bladder cancer is the most common form of bladder cancer. The main problem in ma...